Koenvan BesienMDPhD(He/Him)

PubMed

• 46 citations
  The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Follicular Lymphoma: An Evidence-Based Review
  Denise M. Oliansky, Leo I. Gordon, Jerry King, Ginna G. Laport, John P. Leonard
  Biology of Blood and Marrow Transplantation. 2010-04-01
• 210 citations
  Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
  Nancy L. Bartlett, Donna Niedzwiecki, Jeffrey L. Johnson, Jonathan W. Friedberg, KB Johnson
  Annals of Oncology. 2007-06-01
• 18 citations
  Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation.
  Alexandra Gomez-Arteaga, Elizabeth Margolskee, Mike Wei, Koen van Besien, Giorgio Inghirami
  Leukemia & Lymphoma. 2019-04-18

Abstracts/Posters

• Disease Risk Index (DRI) and Age but Not HCT Comorbidity Index (HCT-CI) Are Predictive of Overall Survival after Cord Blood Transplantation Supported By Haplo-CD34+ pr...
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Thirty-Day Transfusion and G-CSF Requirement after CD19 CAR T Infusion
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Haplo-Cord Transplantation with Anti-Thymocyte Globulin: Comparative Clinical Outcomes with or without Routine G-CSF Administration
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Inferior Survival with Use of Autologous Stem Cell Transplant As Second-Line Therapy in Multiple Myeloma
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Similar Survival with Deferred Versus Salvage Autologous Stem Cell Transplant in Light Chain Amyloidosis
  Koen Van Besien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Hematopoietic Stem Cell Transplant in Novel Agent Era Is Associated with Improved Survival in Relapsed and Refractory Peripheral T-Cell Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• CCR5 delta32 Cord & Haploidentical Grafts: Allogeneic Stem Cell Transplant for HIV+ /AML Patient: A Case Report from the Impaact P1107 Observational StudyClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Targeting the Epichaperome As an Effective Precision Medicine Approach in a Novel PML-SYK Fusion Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all